Efcacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in patients with HCV genotype 1 and 4 infection-fnal data from the real-world AMBer study

This article has no abstract
Epistemonikos ID: 966d62c222e559a942a2ed30b245c6768cf69764
First added on: Feb 08, 2025